Musk Strikes Again: 2026 Marks the Dawn of Mass Production for Brain-Computer Interfaces as Global Race Heats Up for a $100B Market

Recently, American entrepreneur Elon Musk stated on social media that his brain-computer interface company Neuralink will begin mass production of brain-computer interface devices in 2026 and transition to a more streamlined and almost fully automated surgical process.

CSC Financial Research pointed out in its research report that technological advancements in the upstream and midstream of the brain-computer interface industry chain have led to continuous breakthroughs in downstream applications. In recent years, milestone achievements have been made both domestically and internationally in medical fields such as motor function recovery and language communication. Driven by technological innovation and favorable policies, domestic brain-computer interface companies are expected to gradually achieve commercial applications.

Large-scale production will commence this year.

Musk recently stated that Neuralink will launch large-scale mass production of brain-computer interface devices this year and shift to a more streamlined, fully automated surgical process.

It is reported that Neuralink Corp, founded in 2016, is committed to enabling people to directly control computers through neural signals using a coin-sized brain chip. The company is a typical representative of the global invasive brain-computer interface technology route. Its brain-computer interface device can directly insert electrode threads into the dura mater without the need to cut it open, which means less trauma.

Currently, the Neuralink brain implant device primarily targets patients with neurological disorders such as spinal cord injuries. According to company disclosures, as of September 2025, a total of 12 patients with severe paralysis worldwide have been implanted with Neuralink's brain-computer interface device. Implanted patients have been able to accomplish tasks such as playing games, browsing the internet, and posting on social media. This marks a substantial breakthrough in restoring basic communication and environmental control capabilities.

Musk also expressed his hope to achieve the "full-brain brain-machine interface plan" by 2028, which means fully integrating the human brain with AI to realize interconnectivity at the consciousness level. According to Musk's published product roadmap, future developments will cover motion decoding (mainly targeting patients with spinal cord injuries, ALS, and other motor disorders), visual encoding (mainly for visually impaired patients), and an ultimate device called Deep. This device can insert electrodes into any area of the brain, access any region of the brain, and treat neurological diseases such as mental illnesses and pain.

Brain-Computer Interface Commercialization Accelerates in China

In China, companies including StairMed, Neuracle, and BrainCo are accelerating clinical trials, showcasing a development pattern with multiple technical routes running in parallel. The number of implanted patients is expected to increase further by 2026.

In June last year, the first invasive brain-computer interface clinical trial in China, jointly conducted by the Center for Excellence in Brain Science and Intelligence Technology of the Chinese Academy of Sciences, Huashan Hospital Affiliated with Fudan University, and related enterprises, was successfully carried out. China has also become the second country in the world to master and conduct invasive brain-computer interface human trials.

Compared to invasive methods that require craniotomy, semi-invasive approaches (also known as electrocorticography, ECoG) are considered to have greater commercial potential at this stage because they strike a better balance between safety and signal quality. The "Beijing Brain One" GCP multi-center clinical trial, launched in October last year, is the world's first trial of a semi-invasive system with over a hundred channels, wireless, and fully implantable for quasi-practical applications.

Currently, the "BeiNao No.1" intelligent brain-computer system has been successfully implanted in five patients with spinal cord injuries, and the sixth subject is expected to undergo the implant surgery soon. The "BeiNao No.2" system, which boasts superior performance, is also anticipated to enter the clinical validation phase by 2026, with the speed of technological iteration exceeding expectations.

Moreover, Neuracle has achieved outstanding results in the world's first multi-center registered clinical trial of implantable brain-computer interfaces; StairMed released the second-generation 256-channel wireless implantable brain-computer interface system; this year, BrainCo will complete the registration of formal clinical trials for brain-computer interface devices, accelerating the commercialization process of related products. By the end of 2025, the company will have completed 54 human implants of brain-computer interfaces.

In the A-share market, there are currently 39 concept stocks related to brain engineering, with a combined total market value reaching 651.7 billion yuan. Among them, Century Huatong (002602.SZ) and iFlytek (002230.SZ) have market values exceeding 100 billion yuan, while Yanshan Technology (002195.SZ) ranks third with a total market value of 40.2 billion yuan. In terms of market performance, Century Huatong ranked first last year with an increase of 231.91%, while Surmount Medical (603716.SH) and Innovation Medical (002173.SZ) also saw annual increases of over 100%.

Policy Continues to Gain Momentum, Poised to Unlock a Billion-Dollar Market Space

In fact, China released several favorable policies in the brain-computer interface field last year, and regions across the country have been continuously increasing support to accelerate industrial development.

Seven departments, including the Ministry of Industry and Information Technology, previously released the "Implementation Opinions on Promoting the Innovative Development of the Brain-Computer Interface Industry." It proposed that by 2027, key technologies for brain-computer interfaces in China will achieve breakthroughs, and advanced technology, industrial, and standard systems will be preliminarily established. Additionally, the application of brain-computer interface products will accelerate, the industry scale will continue to grow, and 2 to 3 industrial development clusters will be created.

At the local level, Shanghai recently issued the "Several Measures for Comprehensively Deepening the Reform of Drug and Medical Device Regulation to Promote High-Quality Development of the Pharmaceutical Industry," which repeatedly mentions "brain-computer interface." The document calls for focusing on key areas and products such as cell and gene therapy and brain-computer interfaces to establish a service list for key varieties under research. It also emphasizes advancing standardization research for cutting-edge technologies like AI medical devices and brain-computer interfaces.

Beijing Municipal Science and Technology Commission and Zhongguancun Management Committee previously announced plans to establish a dedicated incubation fund for brain-computer interface (BCI) technologies, aiming to create a BCI industry cluster in Zhongguancun. Wuhan East Lake High-Tech Development Zone introduced the "11 Measures for Brain-Computer Interface," focusing on five key areas including strengthening technical product research, promoting the application of technological achievements, and accelerating the development and cultivation of the BCI industry.

CSC Financial believes that the national and regional levels have introduced multiple favorable policies to drive the rapid development of the industry. Recently, the National Healthcare Security Administration issued a document to establish an independent pricing system for new brain-computer interface technologies. With the catalysis of technological innovation and policy benefits, domestic brain-computer interface companies are expected to gradually achieve commercial applications.

In terms of market space, according to data from Precedence Research, the global brain-computer interface market size was approximately US$2.62 billion in 2024, and it is expected to reach US$2.94 billion in 2025. By 2034, it is projected to grow to US$12.4 billion, with a compound annual growth rate (CAGR) of 17.35% over the decade.

       Title: Musk Strikes Again, 2026 to Kick Off Mass Production Era for Brain-Computer Interfaces! Global Race for Billion-Dollar Track in Full Swing